Synergy Pharmaceuticals (SGYP) Stock Higher in After-Hours Trading Following Paulson Investment

NEW YORK (TheStreet) -- Synergy Pharmaceuticals (SGYP) shares continue to climb in after-hours trading today, up 1.03% to $3.93, following reports that John Paulson's Paulson & Co. hedge fund took a position in the gastrointestinal biopharmaceutical company.

Synergy Pharmaceuticals stock closed intraday trading up 10.51% to $3.89 on Monday after Paulson disclosed that it had purchased about 2.1 million shares of the company, a 2.1% stake valued at about $8.3 million.

The purchase makes Paulson the fifth largest shareholder of the New York City-based drug manufacturer.

SGYP Chart SGYP data by YCharts

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists